Peter Altman insider trades

Open-market stock purchases and sales by Peter Altman, President and CEO at BioCardia, Inc, from SEC Form 4 filings since Feb 1, 2018.

Track record: 7% of 85 scored buys are up 5% or more since purchase, averaging -41%.

Recent trades

DateStockTradeValue
Jun 18, 2026BCDA BioCardia, IncBought$768
Jun 17, 2026BCDA BioCardia, IncBought$1.3K
Jun 9, 2026BCDA BioCardia, IncBought$4.3K
May 20, 2026BCDA BioCardia, IncBought$1.4K
May 19, 2026BCDA BioCardia, IncBought$190
May 18, 2026BCDA BioCardia, IncBought$5.2K
May 15, 2026BCDA BioCardia, IncBought$5.2K
Apr 29, 2026BCDA BioCardia, IncBought$5.5K
Apr 21, 2026BCDA BioCardia, IncBought$492
Apr 20, 2026BCDA BioCardia, IncBought$738
Mar 25, 2026BCDA BioCardia, IncBought$366
Mar 24, 2026BCDA BioCardia, IncBought$744
Feb 4, 2026BCDA BioCardia, IncBought$5.7K
Jan 21, 2026BCDA BioCardia, IncBought$402
Jan 20, 2026BCDA BioCardia, IncBought$792
Dec 17, 2025BCDA BioCardia, IncBought$1.2K
Dec 16, 2025BCDA BioCardia, IncBought$274
Dec 8, 2025BCDA BioCardia, IncBought (not open market)$146K
Dec 8, 2025BCDA BioCardia, IncBought (not open market)$77.4K
Dec 8, 2025BCDA BioCardia, IncBought (not open market)—

Companies traded

  • BCDA BioCardia, Inc: 88 buys, last Jun 18, 2026
  • BCDA;BCDAW BioCardia, Inc: 44 buys, 1 sale, last Jul 1, 2024

Get free alerts when Peter Altman files a new trade →